H220-25'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOM
H220-3'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODI
H144-17C5'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 H
AF1'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
AC21'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116


H220-25'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOM
H220-3'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODI
H144-17C5'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 H
AF1'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
AC21'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116


